Jul 17, 2023 7:00am EDT AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets
May 12, 2023 8:00am EDT Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration
May 04, 2023 4:30pm EDT Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC Deregistration
Nov 16, 2022 5:05pm EST Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
Nov 15, 2022 8:00am EST Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights
